Open AccessHydroxychloroquine plus azithromycin and early hospital admission are beneficial in COVID-19 patients: Turkish experience with real-life data
Author(s) -
Elif Tanrıverdi,
Mustafa Çörtük,
Binnaz Zeynep Yıldırım,
Efsun Gonca Uğur Chouseın,
Demet Turan,
Halit Çınarka,
Mehmet Akif Özgül,
Erdoğan Çetınkaya
Publication year - 2021
Publication title -
turkish journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.277
H-Index - 27
eISSN - 1303-6165
pISSN - 1300-0144
DOI - 10.3906/sag-2005-82
Subject(s) - medicine , azithromycin , hydroxychloroquine , procalcitonin , pneumonia , comorbidity , polypharmacy , pediatrics , covid-19 , antibiotics , disease , sepsis , infectious disease (medical specialty) , microbiology and biotechnology , biology
New treatment regimens for COVID-19, which has threatened the world recently, continue to be investigated. Although some of the treatments are promising, it is thought to be early to state that there is definitive treatment. Experiences and treatment protocol studies from treatment centers are still important. The aim of this study is to evaluate factors affecting the treatment process of the first cases followed in our clinic.